BACKGROUND: Pityriasis versicolor (PV) is a common and chronic superficial mycosis seen in all age groups and characterized by dyspigmented lesions caused by dimorphic lipophilic yeast. AIM: The aim of the study was to study the clinical aspects, prevalence, and demographic data of patients with PV in Baghdad City. MATERIALS AND METHODS: Total of 175 patients with PV attending the department of Dermatology at Al Imamein Al Kadhemein Medical City and Alkarama Teaching Hospital in Baghdad city from January 2019 to January 2020 were included in this study. Diagnosis was done clinically. Interviews with patients were done using a questionnaire designed by the researcher. RESULTS: From 175 patients with PV, there were 71 (40.6%) males and 104 (59.4%) females. The mean age was 23.97 ± 10.25 years. The majority of cases 71 (40.6%) were 21–30 years. Eighty-one (46.3%) patients were presented from April to June. Itching presented in 21.7% of patients. The majority of patients (48.6%) presented with hyperpigmented type. Neck was the most common site to be involved in 101 patients (57.7%). CONCLUSION: The most common age group affected was 21–30 years. Females were commonly affected. Peak incidence was observed in April–July months. Neck was the most common site affected. Hyperpigmented type is more commonly presented type.
The FDA-approved vaccine against the novel coronavirus developed by Pfizer and BioNTech became widely popular in Iraq. The study aims to evaluate the incidence of vaccine adverse reactions, and severity after first and second doses and to link some of the demographic criteria of recipients. This study included 850 adults (16 years and older), and the sample was collected from a randomly selected vaccination center in Baghdad, Iraq for the period January to March 2022. Study Participants were directly interviewed while taking the first dose. Later on, phone calls were used to monitor participants' self-reported local or systemic adverse reactions for one week after the first dose and second dose. The participants' age range was (19-76 years) with a mean of (46.2 ± 15.8) years. 59.9% were males. The mean body mass index (BMI) was (27.7 ±2.9). The incidence of vaccine adverse reactions after first and second doses were: first dose (local 17%, systemic 27%), second dose (local 27%, systemic 35%). Ordinal logistic regression analysis after adjusting for age, sex, and past medical history (PMHx) showed a higher incidence and severity in females and those with PMHx in nearly all the types of reactions except for chills (second dose) and PMHx (two doses), muscle or joint pain (two doses). Spearman's Rank test showed an insignificant correlation with any type of reaction. The vaccine is generally safe and adverse reactions are mild and tolerable in the majority of cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.